{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:35Z","timestamp":1787022095617,"version":"build-2736575974"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","award":["Research Fund of Seoul St. Mary\u2019s Hospital"],"award-info":[{"award-number":["Research Fund of Seoul St. Mary\u2019s Hospital"]}],"id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2019R1I1A1A01059642"],"award-info":[{"award-number":["NRF-2019R1I1A1A01059642"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antifibrotic agent for the treatment of liver fibrosis has not been developed so far. Long term treatment of chronic hepatitis B patients with antiviral drugs tenofovir disoproxil fumarate (TDF) and entecavir (ETV) results in the regression of liver fibrosis, but the underlying mechanism has not been clarified. Therefore, we aimed to investigate the direct impact of TDF and ETV on liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Activated hepatic stellate cell (HSC) cell lines were used to evaluate the effects of TDF and ETV. After treatment with each antiviral agent, cell viability, morphology, apoptotic features, autophagy and antifibrosis signalling pathways were examined. Then, collagen deposition, fibrosis markers and activated HSCs were measured in liver tissues of the liver fibrosis model mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After TDF treatment, the viabilities of LX2 and HSC-T6 cells were decreased, and the cells exhibited apoptotic features, but ETV did not induce these effects. Cleavage of PARP and Caspase-3 and the inhibition of the antiapoptotic gene Bcl-xl indicated activated HSC apoptosis following TDF treatment. TDF simultaneously increased autophagy, which also regulated apoptosis through crosstalk. TDF inactivated the PI3K\/Akt\/mTOR signalling pathway, which was associated with the activation of both apoptosis and autophagy. In the liver fibrosis mouse model, the fibrotic area and activated HSC markers were decreased by TDF but not ETV treatment. Additionally, apoptotic cells were concentrated in the periportal fibrotic area after TDF treatment, which indicated the specific antifibrotic effect of TDF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TDF directly ameliorates liver fibrosis by downregulating the PI3K\/Akt\/mTOR signalling pathway, which results in the apoptosis of activated HSCs. The antifibrotic effects of TDF indicate that it may be a therapeutic agent for the treatment of liver fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0261067","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T13:37:56Z","timestamp":1638970676000},"page":"e0261067","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K\/Akt\/mTOR signaling pathway"],"prefix":"10.1371","volume":"16","author":[{"given":"Sung Won","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonhee","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Lim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heechul","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hyun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-4868","authenticated-orcid":true,"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"issue":"3","key":"pone.0261067.ref001","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12072-018-9865-y","article-title":"The growing burden of liver cirrhosis: implications for preventive measures.","volume":"12","author":"MCS Wong","year":"2018","journal-title":"Hepatology international"},{"key":"pone.0261067.ref002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.","volume":"12","author":"AA Mokdad","year":"2014","journal-title":"BMC medicine."},{"issue":"2","key":"pone.0261067.ref003","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"D Schuppan","year":"2018","journal-title":"Journal of hepatology"},{"issue":"1","key":"pone.0261067.ref004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"S Dooley","year":"2012","journal-title":"Cell Tissue Res"},{"issue":"3","key":"pone.0261067.ref005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"P Czochra","year":"2006","journal-title":"Journal of hepatology"},{"issue":"1","key":"pone.0261067.ref006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"SL Friedman","year":"2008","journal-title":"Physiological reviews"},{"issue":"1","key":"pone.0261067.ref007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis","volume":"63","author":"P Kocabayoglu","year":"2015","journal-title":"Journal of hepatology"},{"issue":"5","key":"pone.0261067.ref008","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinre.2019.02.003","article-title":"MicroRNA-101 suppresses liver fibrosis by downregulating PI3K\/Akt\/mTOR signaling pathway.","volume":"43","author":"Y Lei","year":"2019","journal-title":"Clinics and research in hepatology and gastroenterology."},{"issue":"1","key":"pone.0261067.ref009","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Y Wang","year":"2010","journal-title":"Journal of hepatology"},{"issue":"8","key":"pone.0261067.ref010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","article-title":"Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer.","volume":"39","author":"KS Saini","year":"2013","journal-title":"Cancer treatment reviews"},{"issue":"4","key":"pone.0261067.ref011","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3350\/cmh.2019.0056n","article-title":"Inhibition of PI3K\/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail\/GSK-3\/beta-catenin pathway","volume":"26","author":"S Lee","year":"2020","journal-title":"Clinical and molecular hepatology"},{"issue":"9865","key":"pone.0261067.ref012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"P Marcellin","year":"2013","journal-title":"Lancet (London, England)."},{"issue":"32","key":"pone.0261067.ref013","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.3748\/wjg.v21.i32.9598","article-title":"Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy","volume":"21","author":"JL Wang","year":"2015","journal-title":"World journal of gastroenterology"},{"issue":"3","key":"pone.0261067.ref014","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"TT Chang","year":"2010","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"5","key":"pone.0261067.ref015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2020.06.011","article-title":"Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B","volume":"73","author":"GV Papatheodoridis","year":"2020","journal-title":"Journal of hepatology"},{"issue":"8","key":"pone.0261067.ref016","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/jcb.25776","article-title":"RAR-Related Orphan Receptor Gamma (ROR-\u03b3) Mediates Epithelial-Mesenchymal Transition Of Hepatocytes During Hepatic Fibrosis.","volume":"118","author":"SM Kim","year":"2017","journal-title":"J Cell Biochem"},{"key":"pone.0261067.ref017","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-4939-6786-5_19","article-title":"Optimized Mouse Models for Liver Fibrosis.","volume":"1559","author":"YO Kim","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"5","key":"pone.0261067.ref018","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis","volume":"10","author":"AM Elsharkawy","year":"2005","journal-title":"Apoptosis: an international journal on programmed cell death"},{"issue":"12","key":"pone.0261067.ref019","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s12272-012-1219-z","article-title":"Apoptotic effect of propyl gallate in activated rat hepatic stellate cells","volume":"35","author":"XH Che","year":"2012","journal-title":"Archives of pharmacal research"},{"issue":"4","key":"pone.0261067.ref020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","author":"AJ Czaja","year":"2004","journal-title":"Journal of hepatology"},{"issue":"6","key":"pone.0261067.ref021","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"P Hammel","year":"2001","journal-title":"The New England journal of medicine"},{"issue":"4","key":"pone.0261067.ref022","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Long-term survival in patients with hereditary hemochromatosis","volume":"110","author":"C Niederau","year":"1996","journal-title":"Gastroenterology"},{"issue":"8","key":"pone.0261067.ref023","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.bbamcr.2013.02.033","article-title":"Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases","volume":"1833","author":"ME Shaker","year":"2013","journal-title":"Biochimica et biophysica acta"},{"issue":"10","key":"pone.0261067.ref024","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/liv.14155","article-title":"Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection","volume":"39","author":"P Marcellin","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"pone.0261067.ref025","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0016-5085(97)70144-6","article-title":"Phosphatidylinositol 3-kinase is required for platelet-derived growth factor\u2019s actions on hepatic stellate cells","volume":"112","author":"F Marra","year":"1997","journal-title":"Gastroenterology"},{"issue":"10","key":"pone.0261067.ref026","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.M212927200","article-title":"The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression","volume":"278","author":"S Reif","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0261067.ref027","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.17.3.1595","article-title":"Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt","volume":"17","author":"G Kulik","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"2","key":"pone.0261067.ref028","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0168-8278(00)80067-7","article-title":"Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells","volume":"32","author":"A Gentilini","year":"2000","journal-title":"Journal of hepatology"},{"issue":"5338","key":"pone.0261067.ref029","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.278.5338.687","article-title":"Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt","volume":"278","author":"L del Peso","year":"1997","journal-title":"Science"},{"issue":"3","key":"pone.0261067.ref030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis","volume":"112","author":"V Bagnardi","year":"2015","journal-title":"Br J Cancer"},{"issue":"5","key":"pone.0261067.ref031","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/hep.23186","article-title":"Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis","volume":"50","author":"G Son","year":"2009","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"5","key":"pone.0261067.ref032","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/hep.30956","article-title":"Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus Infection","volume":"71","author":"K Murata","year":"2020","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"12","key":"pone.0261067.ref033","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","article-title":"Crosstalk between apoptosis, necrosis and autophagy","volume":"1833","author":"V Nikoletopoulou","year":"2013","journal-title":"Biochimica et biophysica acta"},{"issue":"9","key":"pone.0261067.ref034","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis","volume":"8","author":"MC Maiuri","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"pone.0261067.ref035","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1159\/000495390","article-title":"Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy.","volume":"51","author":"XL Zhang","year":"2018","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology."},{"issue":"12","key":"pone.0261067.ref036","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1634\/theoncologist.12-12-1395","article-title":"Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas.","volume":"12","author":"F Lefranc","year":"2007","journal-title":"The oncologist."},{"issue":"12","key":"pone.0261067.ref037","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"D Heras-Sandoval","year":"2014","journal-title":"Cellular signalling"},{"key":"pone.0261067.ref038","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.omtn.2017.08.011","article-title":"Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR-141-3p\/PTEN\/Akt\/mTOR Pathway.","volume":"9","author":"XY Li","year":"2017","journal-title":"Molecular therapy Nucleic acids"},{"issue":"1","key":"pone.0261067.ref039","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaoncol.2018.4070","article-title":"Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study","volume":"5","author":"J Choi","year":"2019","journal-title":"JAMA oncology"},{"issue":"7","key":"pone.0261067.ref040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/gutjnl-2019-318947","article-title":"Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-na\u00efve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis","volume":"69","author":"SW Lee","year":"2020","journal-title":"Gut"},{"issue":"2","key":"pone.0261067.ref041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3350\/cmh.2019.1002","article-title":"KASL clinical practice guidelines for management of chronic hepatitis B.","volume":"25","author":"Korean Association for the Study of the Liver (KASL)","year":"2019","journal-title":"Clinical and molecular hepatology."},{"issue":"2","key":"pone.0261067.ref042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3350\/cmh.2018.0106","article-title":"Unmet need in chronic hepatitis B management","volume":"25","author":"LY Liang","year":"2019","journal-title":"Clinical and molecular hepatology"},{"issue":"11","key":"pone.0261067.ref043","doi-asserted-by":"crossref","first-page":"e0188135","DOI":"10.1371\/journal.pone.0188135","article-title":"The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin","volume":"12","author":"JL Feig","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"pone.0261067.ref044","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/apt.15965","article-title":"Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issue","volume":"52","author":"SW Lee","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"pone.0261067.ref045","doi-asserted-by":"crossref","first-page":"e69114","DOI":"10.1371\/journal.pone.0069114","article-title":"Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis","volume":"8","author":"DJ Chiang","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"pone.0261067.ref046","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1091\/mbc.E19-03-0136","article-title":"Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling","volume":"30","author":"L Shi","year":"2019","journal-title":"Mol Biol Cell"},{"issue":"5","key":"pone.0261067.ref047","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jbmr.3665","article-title":"Tenofovir Causes Bone Loss via Decreased Bone Formation and Increased Bone Resorption, Which Can Be Counteracted by Dipyridamole in Mice","volume":"34","author":"FM Conesa-Buendatad\u00eda","year":"2019","journal-title":"J Bone Miner Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T13:39:23Z","timestamp":1638970763000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0261067"}},"subtitle":[],"editor":[{"given":"Partha","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0261067","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}